Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy

Steven F. GameiroDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON, CanadaView further author information

Farhad GhasemiDepartment of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, CanadaView further author information

John W. BarrettDepartment of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, CanadaView further author information

James KoropatnickDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada;Department of Oncology, The University of Western Ontario, London, ON, Canada;Department of Pathology, The University of Western Ontario, London, ON, Canada;Department of Physiology and Pharmacology, The University of Western Ontario, London, ON, Canada;London Regional Cancer Program, Lawson Health Research Institute, London, ON, CanadaView further author information

Anthony C. NicholsDepartment of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada;Department of Oncology, The University of Western Ontario, London, ON, Canada;London Regional Cancer Program, Lawson Health Research Institute, London, ON, CanadaView further author information

Joe S. MymrykDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada;Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada;Department of Oncology, The University of Western Ontario, London, ON, Canada;London Regional Cancer Program, Lawson Health Research Institute, London, ON, CanadaView further author information

Saman Maleki VarekiDepartment of Oncology, The University of Western Ontario, London, ON, Canada;London Regional Cancer Program, Lawson Health Research Institute, London, ON, CanadaCorrespondence[email protected]
View further author information

show all

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date